🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Lycia Therapeutics, Inc. (LYCA)
NASDAQ: LYCA · Real-Time Price · USD
33.07
+1.30 (4.09%)
At close: Nov 20, 2026, 4:00 PM EST
33.30
+0.23 (0.70%)
After-hours: Nov 20, 2026, 7:30 PM EST

Lycia Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Net Income
-30.03-36.46-26.5
Depreciation & Amortization
2.462.842.39
Asset Writedown & Restructuring Costs
-0.49-
Loss (Gain) From Sale of Investments
-1.13-1.77-2.91
Stock-Based Compensation
0.961.10.79
Other Operating Activities
-0.040.11-0
Change in Accounts Payable
-1.53-1.231.45
Change in Unearned Revenue
-2.44-4.74-14.94
Change in Other Net Operating Assets
-2.01-11.6910.22
Operating Cash Flow
-33.75-51.36-29.5
Operating Cash Flow Growth
---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Capital Expenditures
-0.03-0.19-1.27
Sale of Property, Plant & Equipment
0.110.04-
Investment in Securities
-5.4140.12-58.44
Investing Cash Flow
-5.3439.96-59.71

Financing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Issuance of Common Stock
0.140.080.18
Repurchase of Common Stock
--0-
Other Financing Activities
-0.43--0.36
Financing Cash Flow
74.710.08106.42

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Net Cash Flow
35.62-11.3217.21

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Free Cash Flow
-33.79-51.56-30.77
Free Cash Flow Growth
---
Free Cash Flow Margin
-761.83%-764.81%-206.03%
Free Cash Flow Per Share
-2.35-3.66-2.30
Levered Free Cash Flow
--36.92-
Unlevered Free Cash Flow
--36.9-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Cash Income Tax Paid
000.09
Change in Working Capital
-5.97-17.66-3.27
SEC Filings: 10-K · 10-Q